Richard C. Bates
Division of Cancer Biology and Angiogenesis
Department of Pathology
Beth Israel Deaconess Medical Center and Harvard Medical School
Boston
USA
Name/email consistency: high
- Transcriptional activation of integrin beta6 during the epithelial-mesenchymal transition defines a novel prognostic indicator of aggressive colon carcinoma. Bates, R.C., Bellovin, D.I., Brown, C., Maynard, E., Wu, B., Kawakatsu, H., Sheppard, D., Oettgen, P., Mercurio, A.M. J. Clin. Invest. (2005)
- The epithelial-mesenchymal transition of colon carcinoma involves expression of IL-8 and CXCR-1-mediated chemotaxis. Bates, R.C., DeLeo, M.J., Mercurio, A.M. Exp. Cell Res. (2004)
- Tumor necrosis factor-alpha stimulates the epithelial-to-mesenchymal transition of human colonic organoids. Bates, R.C., Mercurio, A.M. Mol. Biol. Cell (2003)
- Flt-1-dependent survival characterizes the epithelial-mesenchymal transition of colonic organoids. Bates, R.C., Goldsmith, J.D., Bachelder, R.E., Brown, C., Shibuya, M., Oettgen, P., Mercurio, A.M. Curr. Biol. (2003)
- A CD44 survival pathway triggers chemoresistance via lyn kinase and phosphoinositide 3-kinase/Akt in colon carcinoma cells. Bates, R.C., Edwards, N.S., Burns, G.F., Fisher, D.E. Cancer Res. (2001)